PRVA / Privia Health Group, Inc. - تصريحات هيئة الأوراق المالية والبورصات، التقرير السنوي، بيان الوكيل

Privia Health ACOs Delivered $233+ Million in Total Savings in the 2024 Performance Year of Medicare Shared Savings Program, a 32% Year-over-Year Increase

Exhibit 99.1 Privia Health ACOs Delivered $233+ Million in Total Savings in the 2024 Performance Year of Medicare Shared Savings Program, a 32% Year-over-Year Increase •Mid-Atlantic ACO Realized Highest Savings Rate of All ACOs with 40,000+ Attributed Lives •Company Increases Adjusted EBITDA Guidance for Full-Year 2025 ARLINGTON, VA – August 28, 2025 – Privia Health Group, Inc. (Nasdaq: PRVA) toda

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 28, 2025 Privia Health Gro

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 28, 2025 Privia Health Group, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware 001-40365 81-3599420 (State or other jurisdiction of incorporation or organiz

Privia Health Reports Second Quarter 2025 Financial Results

Exhibit 99.1 Privia Health Reports Second Quarter 2025 Financial Results –Very Strong First Half Performance Across All Key Operating and Financial Metrics –Implemented Providers +13.8% and Practice Collections +18.5% compared to 2Q’24 –Guidance Raised to Above High End of Range for Practice Collections, GAAP Revenue, Platform Contribution and Adjusted EBITDA c ARLINGTON, VA – August 7, 2025 – Pri

Privia Health Annual Cash Incentive Plan

Exhibit 10.1 Annual Cash Incentive Plan I. Plan Objective The purpose of the Annual Incentive Plan (the "Plan") of Privia Health Group, Inc. (the "Company") is to promote the interests of the Company by providing additional incentive for employees who contribute to the improvement of the Company's operating results and to reward outstanding performance by those individuals whose decisions and acti

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 7, 2025 Privia Health Grou

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 7, 2025 Privia Health Group, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware 001-40365 81-3599420 (State or other jurisdiction of incorporation or organiza

Privia Health Announces Appointment of Lance V. Berberian to its Board of Directors Berberian brings significant technology leadership and cybersecurity expertise

Exhibit 99.1 Privia Health Announces Appointment of Lance V. Berberian to its Board of Directors Berberian brings significant technology leadership and cybersecurity expertise ARLINGTON, VA – July 8, 2025 – Privia Health Group, Inc. (Nasdaq: PRVA) announced the appointment of Lance V. Berberian to its Board of Directors, effective July 15, 2025. He has also been named a member of the Audit Committ

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 3, 2025 Privia Health Group, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware 001-40365 81-3599420 (State or other jurisdiction of incorporation or organizati

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 21, 2025 Privia Health Group,

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 21, 2025 Privia Health Group, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware 001-40365 81-3599420 (State or other jurisdiction of incorporation or organizati

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. )

DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.

mployment Agreement first amendment between Privia

Exhibit 10.3 FIRST AMENDMENT TO EXECUTIVE EMPLOYMENT AGREEMENT This FIRST AMENDMENT TO EXECUTIVE EMPLOYMENT AGREEMENT (this “Amendment”), effective March 3, 2025, is entered into by and between Privia Health, LLC (“Company”) and Edward C. Fargis (“Executive”). Each of Company and Executive may be referred to individually herein as a “Party” or, collectively, as the “Parties.” RECITALS WHEREAS, Com

Employment Agreement second amendment between Privia Health Group, Inc. and David Mountcastle

Exhibit 10.2 SECOND AMENDMENT TO EXECUTIVE EMPLOYMENT AGREEMENT This SECOND AMENDMENT TO EXECUTIVE EMPLOYMENT AGREEMENT (this “Amendment”), effective March 3, 2025, is entered into by and between Privia Health, LLC (“Company”) and David Mountcastle (“Executive”). Each of Company and Executive may be referred to individually herein as a “Party” or, collectively, as the “Parties.” RECITALS WHEREAS,

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 8, 2025 Privia Health Group,

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 8, 2025 Privia Health Group, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware 001-40365 81-3599420 (State or other jurisdiction of incorporation or organizatio

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 00

Privia Health Reports First Quarter 2025 Financial Results

Exhibit 99.1 Privia Health Reports First Quarter 2025 Financial Results –Strong First Quarter Performance and Operating Execution –Enters the State of Arizona –Full-Year 2025 Outlook Raised to Mid- to High End of Guidance Ranges for All Metrics with Attributed Lives Unchanged ARLINGTON, VA – May 8, 2025 – Privia Health Group, Inc. (Nasdaq: PRVA) today announced financial results for the first quar

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amend

DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. )

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.

Employment Agreement fifth amendment between Privia Health Group, Inc. and Parth Mehrotra dated March 3, 2025 (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on March 7, 2025).

Exhibit 10.1 FIFTH AMENDMENT TO EXECUTIVE EMPLOYMENT AGREEMENT This FIFTH AMENDMENT TO EXECUTIVE EMPLOYMENT AGREEMENT (this “Amendment”), effective March 3, 2025, is entered into by and between Privia Health, LLC (“Company”) and Parth Mehrotra (“Executive”). Each of Company and Executive may be referred to individually herein as a “Party” or, collectively, as the “Parties.” RECITALS WHEREAS, Compa

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 3, 2025 Privia Health Group, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware 001-40365 81-3599420 (State or other jurisdiction of incorporation or organizat

Form of Restricted Stock Unit Award for SVP+ Employees under the 2021 Omnibus Incentive Plan

Exhibit 10.35 PRIVIA HEALTH GROUP, INC. 2021 OMNIBUS INCENTIVE PLAN NOTICE OF RESTRICTED STOCK UNIT AWARD Privia Health Group, Inc., a Delaware corporation (the “Company”), has granted the individual listed below as the Participant, effective as of the Grant Date (as set forth below), a Restricted Stock Unit Award (the “Award”) under the Privia Health Group, Inc. 2021 Omnibus Incentive Plan (as am

Insider Trading Policy (filed herewith)

Exhibit 19.1 Privia Health Group, Inc. Insider Trading Compliance Policy As amended May 22, 2024 US-LEGAL-12784112/2 177206-0002 TABLE OF CONTENTS II THE USE OF INSIDE INFORMATION IN CONNECTION WITH TRADING IN SECURITIES 1 A. General Rule. 1 B. Who Does the Policy Apply To? 4 C. Other Companies’ Stock. 4 D. Hedging and Derivatives. 5 E. Pledging of Securities, Margin Accounts. 5 F. General Guideli

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the year ended December 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-40365 Priv

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 27, 2025 Privia Health Group, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware 001-40365 81-3599420 (State or other jurisdiction of incorporation or organ

Subsidiaries of the registrant

Exhibit 21.1 List of Subsidiaries of Privia Health Group, Inc. Legal Name of Entity Jurisdiction of Formation BASS Privia Management Company of California, LLC CA Berdayes Medical Association, PLLC TX CMG ACO, LLC CT Complete MD Solutions, LLC TX Patient Health Advocacy Solutions, LLC DE PH Group Holdings Corp. (f/k/a Brighton Health Services Holdings Corp.) DE PMG Holdings Indiana, LLC IN PMG Phy

Privia Health Reports Fourth Quarter and Full-Year 2024 Financial Results

Exhibit 99.1 Privia Health Reports Fourth Quarter and Full-Year 2024 Financial Results –All 2024 Operating and Financial Metrics Above High End of Guidance Ranges –Very strong New Provider Signings; Implemented Providers +11.2% from Year-end 2023 –Full-year 2024 Net Cash Provided by Operating Activities of $109.3 million, +35.3% from 2023, with De Minimis Capital Expenditures –Year-end 2024 Cash B

Regulation FD Disclosure, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 13, 2025 Privia Health Group, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware 001-40365 81-3599420 (State or other jurisdiction of incorporation or organi

J.P. Morgan 2025 Healthcare Conference January 2025 Investor Presentation Forward-Looking Statements This presentation contains forward-looking statements that express the Company’s opinions, expectations, beliefs, plans, objectives, assumptions or p

J.P. Morgan 2025 Healthcare Conference January 2025 Investor Presentation Forward-Looking Statements This presentation contains forward-looking statements that express the Company’s opinions, expectations, beliefs, plans, objectives, assumptions or projections regarding future events or future results that include, but are not limited to: 2024 financial guidance and other projections and forecasts

PRVA / Privia Health Group, Inc. / Durable Capital Partners LP - AMENDMENT TO SC 13G Passive Investment

SC 13G/A 1 privia-sc13ga093024.htm AMENDMENT TO SC 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* Privia Health Group, Inc. (Name of Issuer) Common Stock, $0.01 par value per share (Title of Class of Securities) 74276R102 (CUSIP Number) September 30, 2024 (Date of Event Which Requires Filing of t

Filing Fee Table

Exhibit 107.1 C ALCULATION OF F ILING F EE T ABLE Form S-8 (Form Type) Privia Health Group, Inc. (Exact name of registrant as specified in its charter) Table 1: Newly Registered Securities Security Type Security Class Title Fee Calculation  Rule Amount to be Registered (1) Proposed Maximum Offering Price Per Share Proposed Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Equity

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 7, 2024 Privia Health Group, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware 001-40365 81-3599420 (State or other jurisdiction of incorporation or organi

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file numbe

Privia Health Reports Third Quarter 2024 Financial Results

Exhibit 99.1 Privia Health Reports Third Quarter 2024 Financial Results –Strong Execution Across All Business and Financial Metrics –Raised Full-Year 2024 Guidance to At or Above the High End for All Metrics –Announced New Market Entry in Indiana –Achieved MSSP 2023 Shared Saving of $176.6 Million, +34.1% versus 2023 –Strong Adjusted EBITDA Growth and Free Cash Flow Generation ARLINGTON, VA – Nove

As filed with the Securities and Exchange Commission on November 7, 2024

S-8 As filed with the Securities and Exchange Commission on November 7, 2024 Registration No.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001

Privia Health Reports Second Quarter 2024 Financial Results

Exhibit 99.1 Privia Health Reports Second Quarter 2024 Financial Results –Strong Execution Across All Business and Financial Metrics –Raised Full-Year 2024 Guidance to Mid to High End for All Metrics ARLINGTON, VA – August 8, 2024 – Privia Health Group, Inc. (Nasdaq: PRVA) today announced financial results for the second quarter and six months ended June 30, 2024. Second Quarter Performance For th

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 8, 2024 Privia Health Group, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware 001-40365 81-3599420 (State or other jurisdiction of incorporation or organiza

PRVA / Privia Health Group, Inc. / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment

SC 13G/A 1 tv0027-priviahealthgroupinc.htm SCHEDULE 13G/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 1)* Name of issuer: Privia Health Group Inc Title of Class of Securities: Common Stock CUSIP Number: 74276R102 Date of Event Which Requires Filing of this Statement: June 28, 2024 Check the appropriate box to desi

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 1, 2024 Privia Health Group, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware 001-40365 81-3599420 (State or other jurisdiction of incorporation or organizati

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 5, 2024 Privia Health Group,

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 5, 2024 Privia Health Group, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware 001-40365 81-3599420 (State or other jurisdiction of incorporation or organizati

1 William Blair 44th Annual Growth Stock Conference June 5, 2024 2 Forward-Looking Statements This presentation contains forward-looking statements that express the Company’s opinions, expectations, beliefs, plans, objectives, assumptions or projecti

prvawmblairpresentation- 1 William Blair 44th Annual Growth Stock Conference June 5, 2024 2 Forward-Looking Statements This presentation contains forward-looking statements that express the Company’s opinions, expectations, beliefs, plans, objectives, assumptions or projections regarding future events or future results that include, but are not limited to: 2024 financial guidance and other projections and forecasts.

Submission of Matters to a Vote of Security Holders

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A (Amendment No. 1) CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 22, 2024 Privia Health Group, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware 001-40365 81-3599420 (State or other jurisdiction of incorpo

Second Amended & Restated Certificate of Incorporation of Privia Health Group, Inc. (incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K filed on May 23, 2024).

Exhibit 3.1 SECOND AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF PRIVIA HEALTH GROUP, INC. Privia Health Group, Inc., a corporation organized and existing under the laws of the State of Delaware (the “Corporation”), hereby certifies that the Corporation was originally incorporated under the name “PH Group Parent Corp.” on August 10, 2016, and that its original Certificate of Incorporation w

Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits, Submission of Matters to a Vote of Security Holders

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 22, 2024 Privia Health Group, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware 001-40365 81-3599420 (State or other jurisdiction of incorporation or organizati

Fourth Amended & Restated Bylaws of Privia Health Group, Inc. (incorporated by reference to Exhibit 3.2 to the Company’s Current Report on Form 8-K filed on May 23, 2024).

Exhibit 3.2 FOURTH AMENDED AND RESTATED BYLAWS OF PRIVIA HEALTH GROUP, INC., a Delaware Corporation (the “Corporation”) Adopted and in effect as of May 22, 2024 ***** ARTICLE 1 OFFICES Section 1.01. Registered Office. The registered office of the Corporation shall be in the State of Delaware, as designated from time to time by the appropriate filing by the Corporation in the office of the Secretar

Privia Health Reports First Quarter 2024 Financial Results

Exhibit 99.1 Privia Health Reports First Quarter 2024 Financial Results –Practice Collections +7.4% compared to 1Q’23 –Implemented Providers +17.3% compared to 1Q’23 –Company Reiterated Full Year 2024 Guidance ARLINGTON, VA – May 9, 2024 – Privia Health Group, Inc. (Nasdaq: PRVA) today announced financial results for the first quarter ended March 31, 2024. For the Three Months Ended March 31, ($ i

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 00

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 9, 2024 Privia Health Group,

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 9, 2024 Privia Health Group, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware 001-40365 81-3599420 (State or other jurisdiction of incorporation or organizatio

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amend

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. )

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. )

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.

Privia Health Reports Fourth Quarter and Full-Year 2023 Financial Results

Exhibit 99.1 Privia Health Reports Fourth Quarter and Full-Year 2023 Financial Results –Achieved All 2023 Operating and Financial Guidance Metrics –Implemented Providers +19.4% compared to Year-End 2022 –Introduces Full-Year 2024 Guidance –Proactive Steps to Limit Downside Risk Arrangements in Current Medicare Advantage Environment for More Favorable Contract Structures and Margin Contribution ARL

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 27, 2024 Privia Health Group, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware 001-40365 81-3599420 (State or other jurisdiction of incorporation or organ

Employment Agreement between Privia Health Group, Inc. and Edward Fargis dated January 29, 2024

Exhibit 10.1 Executive Employment Agreement This Executive Employment Agreement (“Agreement”) entered into as of the 25th day of January, 2024 (“Effective Date”), by and between Privia Health, LLC (“Company”) and Edward C. Fargis (“Executive”), together (the “Parties”). Recitals WHEREAS, Company is engaged in the business of owning, operating and providing management services to certain accountabl

Policy Relating to Recovery of Erroneously Awarded Compensation

Exhibit 97.1 NOTICE OF PRIVIA HEALTH GROUP, INC. POLICY FOR RECOVERY OF ERRONEOUSLY AWARDED COMPENSATION Attached hereto is a copy of the Privia Health Group, Inc. Policy for Recovery of Erroneously Awarded Compensation (as may be amended, restated, supplemented or otherwise modified from time to time, the “Policy”). Capitalized terms used but not otherwise defined in this Acknowledgement Form (th

Subsidiaries of the registrant

Exhibit 21.1 List of Subsidiaries of Privia Health Group, Inc. Legal Name of Entity Jurisdiction of Formation BASS Privia Management Company of California, LLC CA CMG ACO, LLC CT Complete MD Solutions, LLC TX Patient Health Advocacy Solutions, LLC DE PH Group Holdings Corp. (f/k/a Brighton Health Services Holdings Corp.) DE PMG POL, LLC DE PMG South Carolina Holdings, PLLC SC PMG Washington Holdin

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the year ended December 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-40365 Priv

PRVA / Privia Health Group, Inc. / VANGUARD GROUP INC - SCHEDULE 13G Passive Investment

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 Name of issuer: Privia Health Group Inc Title of Class of Securities: Common Stock CUSIP Number: 74276R102 Date of Event Which Requires Filing of this Statement: December 29, 2023 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ☒ Rule 13d-1(b) ☐

Privia Health Appoints Edward C. Fargis as General Counsel

Exhibit 99.1 Privia Health Appoints Edward C. Fargis as General Counsel ARLINGTON, VA – January 29, 2024 – Privia Health (Nasdaq: PRVA), announced that Edward C. Fargis has been named Executive Vice President, General Counsel and Corporate Secretary, effective today. Mr. Fargis will serve as the Company's chief legal officer, working with Privia executive leadership to support the Company's long-t

Transition Letter Agreement, dated as of January 25, 2024, between the Company and Thomas Bartrum

Exhibit 10.1 Mr. Thomas Bartrum January 25, 2024 Re: Transition and Release of Claims Dear Thomas: This letter agreement (this “Letter Agreement”), entered into on the date first set forth above (the “Effective Date”), sets forth the understanding by and between you, Privia Health, LLC (“Employer”), and Privia Health Group, Inc. (“PHG” and collectively with Employer, the “Company”), regarding your

Regulation FD Disclosure, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 25, 2024 Privia Health Group, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware 001-40365 81-3599420 (State or other jurisdiction of incorporation or organi

1 Investor Presentation J.P. Morgan Healthcare Conference January 8, 2024 2 Forward-Looking Statements This presentation contains forward-looking statements that express the Company’s opinions, expectations, beliefs, plans, objectives, assumptions or

1 Investor Presentation J.P. Morgan Healthcare Conference January 8, 2024 2 Forward-Looking Statements This presentation contains forward-looking statements that express the Company’s opinions, expectations, beliefs, plans, objectives, assumptions or projections regarding future events or future results that include, but are not limited to: 2023 financial guidance and other projections and forecas

Regulation FD Disclosure, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 8, 2024 Privia Health Group, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware 001-40365 81-3599420 (State or other jurisdiction of incorporation or organiz

, 2023 among Privia Health Group, Inc., PH Group Holdings Corp., and Privia Health, LLC, as borrower,

Exhibit 10.1 Execution Version Published CUSIP Number: 74276YAA5 Revolving Credit CUSIP Number: 74276YAB3 $125,000,000 CREDIT AGREEMENT dated as of November 16, 2023, by and among PRIVIA HEALTH GROUP, INC., as Holdings, PH GROUP HOLDINGS CORP., as Intermediate Holdings, PRIVIA HEALTH, LLC, as Borrower, the Lenders referred to herein, as Lenders, and WELLS FARGO BANK, NATIONAL ASSOCIATION, as Admin

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 16, 2023 Privia Health G

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 16, 2023 Privia Health Group, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware 001-40365 81-3599420 (State or other jurisdiction of incorporation or organ

Privia Health Reports Third Quarter 2023 Financial Results; Announces New Market Entry in South Carolina

Exhibit 99.1 Privia Health Reports Third Quarter 2023 Financial Results; Announces New Market Entry in South Carolina –Practice Collections +18.2% compared to 3Q’22 –Implemented Providers +14.2% compared to 3Q’22 –Company Updated Full Year 2023 Guidance ARLINGTON, VA – November 3, 2023 – Privia Health Group, Inc. (Nasdaq: PRVA) today announced financial results for the third quarter and nine month

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file numbe

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 3, 2023 Privia Health Group, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware 001-40365 81-3599420 (State or other jurisdiction of incorporation or organi

Privia Health Reports Second Quarter 2023 Financial Results

Exhibit 99.1 Privia Health Reports Second Quarter 2023 Financial Results –Practice Collections +13.7% compared to 2Q’22 –Implemented Providers +9.3% compared to 2Q’22 –Company Updated Full Year 2023 Guidance ARLINGTON, VA – August 3, 2023 – Privia Health Group, Inc. (Nasdaq: PRVA) today announced financial results for the second quarter and six month periods ended June 30, 2023. Second Quarter Tot

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 3, 2023 Privia Health Group, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware 001-40365 81-3599420 (State or other jurisdiction of incorporation or organiza

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 31, 2023 Privia Health Group

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 31, 2023 Privia Health Group, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware 001-40365 81-3599420 (State or other jurisdiction of incorporation or organizat

Amended and Restated Bylaws dated August 1, 2023 (incorporated by reference to Exhibit 3.1 to the Company's Current Report on Form 8-K filed on July 31, 2023

Exhibit 3.1 THIRD AMENDED AND RESTATED BYLAWS OF PRIVIA HEALTH GROUP, INC., a Delaware Corporation (the “Corporation”) Adopted and in effect as of August 1, 2023 ***** ARTICLE 1 OFFICES Section 1.01. Registered Office. The registered office of the Corporation shall be in the State of Delaware, as designated from time to time by the appropriate filing by the Corporation in the office of the Secreta

Privia Health Announces Changes to Board of Directors Distinguished Healthcare Leader Dave Wichmann and Seasoned CHRO Pam Kimmet to Join Board

Exhibit 99.1 Privia Health Announces Changes to Board of Directors Distinguished Healthcare Leader Dave Wichmann and Seasoned CHRO Pam Kimmet to Join Board ARLINGTON, VA – July 31, 2023 – Privia Health Group, Inc. (Nasdaq: PRVA) today announced the election of David S. Wichmann and Pamela O. Kimmet to its Board of Directors, effective August 1, 2023. Jeff Bernstein, Managing Director of Goldman Sa

Relative TSR PSU Agreement, effective July 1, 2023

Exhibit 10.2 PRIVIA HEALTH GROUP, INC. 2021 OMNIBUS INCENTIVE PLAN NOTICE OF PERFORMANCE STOCK UNIT AWARD July 1, 2023 Privia Health Group, Inc., a Delaware corporation (the “Company”), has granted the individual listed below as the Participant, effective as of the Grant Date (as set forth below), an award of Performance Stock Units (the “PSUs” or the “Award”) under the Privia Health Group, Inc. 2

Mehrotra Fourth Amendment to Employment Agreement, dated June 23, 2023

Exhibit 10.1 FOURTH AMENDMENT TO EXECUTIVE EMPLOYMENT AGREEMENT THIS FOURTH AMENDMENT TO EXECUTIVE EMPLOYMENT AGREEMENT (the “Amendment”) dated June 23, 2023 and effective July 1, 2023 (the “Effective Date”), is entered into by and between Privia Health, LLC (“Company”), Parth Mehrotra (“Executive”) and for purposes of Exhibit B, Privia Health Group, Inc. (“PHG”). Each of Company, PHG and Executiv

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 23, 2023 Privia Health Group

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 23, 2023 Privia Health Group, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware 001-40365 81-3599420 (State or other jurisdiction of incorporation) (Commission

Morris Transition Agreement, dated June 23, 2023

Exhibit 10.3 Mr. Matthew Shawn Morris June 23, 2023 Re: Transition and Release of Claims Dear Shawn: This letter agreement (this “Letter Agreement”), entered into on the date first set forth above (the “Effective Date”), sets forth the understanding by and between you, Privia Health, LLC (“Employer”) and Privia Health Group, Inc. (“PHG” and collectively with Employer, the “Company”), regarding you

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 24, 2023 Privia Health Group,

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 24, 2023 Privia Health Group, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware 001-40365 81-3599420 (State or other jurisdiction of incorporation or organizati

PRVA / Privia Health Group Inc / Durable Capital Partners LP - FORM SC 13G Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Privia Health Group, Inc. (Name of Issuer) Common Stock, $0.01 par value per share (Title of Class of Securities) 74276R102 (CUSIP Number) May 4, 2023 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule

PRVA / Privia Health Group Inc / Pamplona Capital Partners III, L.P. Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 9, 2023 Privia Health Group,

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 9, 2023 Privia Health Group, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware 001-40365 81-3599420 (State or other jurisdiction of incorporation or organizatio

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amend

DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 4, 2023 Privia Health Group,

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 4, 2023 Privia Health Group, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware 001-40365 81-3599420 (State or other jurisdiction of incorporation or organizatio

Underwriting Agreement, dated as of May 4, 2023, by and among the Company, the Selling Stockholders and the Underwriter.

Exhibit 1.1 Privia Health Group, Inc. Common Stock Underwriting Agreement May 4, 2023 Goldman Sachs & Co. LLC 200 West Street New York, New York 10282-2198 Ladies and Gentlemen: The stockholders of Privia Health Group, Inc., a Delaware corporation (the “Company”) named in Schedule I hereto (the “Selling Stockholders”) propose, subject to the terms and conditions stated in this agreement (this “Agr

Information Relating to Part II, Item 14. Other Expenses of Issuance and Distribution

Exhibit 99.1 Information Relating to Part II, Item 14. Other Expenses of Issuance and Distribution The following is a statement of the expenses incurred or expected to be incurred, other than underwriting discounts and commissions, to be paid solely by Privia Health Group, Inc., in connection with the issuance and distribution of the securities being registered hereby. All expenses other than the

42,561,196 Shares Privia Health Group, Inc. Common Stock

Filed Pursuant to Rule 424(b)(7) File No. 333-268394 Prospectus Supplement (To Prospectus dated November 15, 2022) 42,561,196 Shares Privia Health Group, Inc. Common Stock The selling stockholders of Privia Health Group, Inc. (“Privia Health” or “we”) named in this prospectus supplement are selling 42,561,196 shares of Privia Health’s common stock. We are not selling any shares under this prospect

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 4, 2023 Privia Health Group,

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 4, 2023 Privia Health Group, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware 001-40365 81-3599420 (State or other jurisdiction of incorporation or organizatio

Privia Health Reports First Quarter 2023 Financial Results

Exhibit 99.1 Privia Health Reports First Quarter 2023 Financial Results –Practice Collections +17.3% compared to 1Q’22 –Implemented Providers +10.3% compared to 1Q’22 –Company Reiterated Full Year 2023 Guidance ARLINGTON, VA – May 4, 2023 – Privia Health Group, Inc. (Nasdaq: PRVA) today announced financial results for the first quarter ended March 31, 2023. Total revenue for the first quarter of 2

Form of PSU Award Agreement under the 2021 Omnibus Incentive Plan

Exhibit 10.1 PRIVIA HEALTH GROUP, INC. 2021 OMNIBUS INCENTIVE PLAN NOTICE OF PERFORMANCE STOCK UNIT AWARD [DATE] Privia Health Group, Inc., a Delaware corporation (the “Company”), has granted the individual listed below as the Participant, effective as of the Grant Date (as set forth below), an award of Performance Stock Units (the “PSUs” or the “Award”) under the Privia Health Group, Inc. 2021 Om

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 00

Subject to completion dated May 4, 2023

Filed Pursuant to Rule 424(b)(7) File No. 333-268394 The information in this preliminary prospectus supplement is not complete and may be changed. A registration statement relating to these securities has been filed with the Securities and Exchange Commission and is effective. This preliminary prospectus supplement and the accompanying prospectus are not an offer to sell these securities and they

April 17, 2023

Privia Health 950 N. Glebe Road, Suite 700 Arlington, VA 22203 April 17, 2023 Division of Corporation Finance U.S. Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Attn: Christie Wong and Julie Sherman Re: Privia Health Group, Inc. Form 10-K for the Fiscal Year Ended December 31, 2022 Filed March 1, 2023 File No. 001-40365 Dear Christie Wong and Julie Sherman: On behalf

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 7, 2023 Privia Health Group

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 7, 2023 Privia Health Group, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware 001-40365 81-3599420 (State or other jurisdiction of incorporation or organizat

Privia Health Announces Leadership Succession Current President and COO Parth Mehrotra Named CEO; Shawn Morris to Retire and Remain on Board of Directors

Exhibit 99.1 Privia Health Announces Leadership Succession Current President and COO Parth Mehrotra Named CEO; Shawn Morris to Retire and Remain on Board of Directors ARLINGTON, VA – April 12, 2023 – Privia Health (Nasdaq: PRVA), a technology-driven, national physician enablement company, today announced that Parth Mehrotra, currently the Company’s President and Chief Operating Officer, has been n

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amend

DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amend

DEFA14A Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amend

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 16, 2023 Privia Health Grou

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 16, 2023 Privia Health Group, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware 001-40365 81-3599420 (State or other jurisdiction of incorporation or organiza

Strategic Alignment Agreement, dated as of March 2, 2023, by and between Privia Health Group, Inc. and ChoiceHealth, Inc.

ex101-priviaxnovantxstra US-DOCS\137686120.15 STRATEGIC ALIGNMENT AGREEMENT This STRATEGIC ALIGNMENT AGREEMENT (this “Agreement”) is made and entered into as of March 2, 2023 by and among Privia Health Group, Inc., a Delaware corporation (the “Company”), and ChoiceHealth, Inc. (“Novant”). RECITALS A. On November 3, 2022, Novant and Privia Management Company, LLC, a wholly owned subsidiary of the C

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 2, 2023 Privia Health Group

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 2, 2023 Privia Health Group, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware 001-40365 81-3599420 (State or other jurisdiction of incorporation or organizat

Subsidiaries of the registrant

Exhibit 21.1 List of Subsidiaries of Privia Health Group, Inc. Legal Name of Entity Jurisdiction of Formation BASS Privia Management Company of California, LLC CA Complete MD Solutions, LLC TX Patient Health Advocacy Solutions, LLC DE PH Group Holdings Corp. (f/k/a Brighton Health Services Holdings Corp.) DE PMG POL, LLC DE PMG West Texas Holdings, PLLC TX PMG-TN Physicians, PLLC TN PQN-Central Te

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the year ended December 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-40365 Priv

Privia Health Reports Fourth Quarter 2022 Financial Results

Exhibit 99.1 Privia Health Reports Fourth Quarter 2022 Financial Results –FY 2022 Financial Results At or Above High End of Guidance with Practice Collections Growth of 49.1% compared to FY 2021 –New Market Entries announced in Connecticut, Delaware, North Carolina and Ohio –Launches Three New ACOs; Five ACOs now participating in MSSP Enhanced Track –2023 Capitated Lives Increase 38%+ to 40,600 Pa

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 28, 2023 Privia Health G

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 28, 2023 Privia Health Group, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware 001-40365 81-3599420 (State or other jurisdiction of incorporation or organ

PRVA / Privia Health Group, Inc. / Pamplona Capital Partners III, L.P. Passive Investment

SC 13G/A 1 formsc13ga.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2)* Privia Health Group, Inc. (Name of Issuer) Common Stock, $0.01 par value per share (Title of Class of Securities) 74276R102 (CUSIP Number) December 31, 2022 (Date of Event Which Requires Filing of this Statement) Check the appropr

PRVA / Privia Health Group, Inc. / Sullivan William M - SC 13G Passive Investment

SC 13G 1 d635990dsc13g.htm SC 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. ) * Privia Health Group, Inc. (Name of Issuer) Common Stock, $.01 par value (Title of Class of Securities) 74276R102 (CUSIP Number) December 31, 2022 (Date of Event which Requires Filing of this Statement) Check the appropri

JOINT FILING STATEMENT PURSUANT TO RULE 13d-1(k)

EX-1 2 ex1.htm EXHIBIT 1 JOINT FILING STATEMENT PURSUANT TO RULE 13d-1(k) The undersigned acknowledge and agree that the foregoing statement on Schedule 13G, is filed on behalf of each of the undersigned and that all subsequent amendments to this statement on Schedule 13G, shall be filed on behalf of each of the undersigned without the necessity of filing additional joint acquisition statements. T

1 Empowering Physicians Transforming Healthcare J.P. Morgan Healthcare Conference January 9, 2023 2 Forward-Looking Statements This presentation contains forward-looking statements that express the Company’s opinions, expectations, beliefs, plans, ob

1 Empowering Physicians Transforming Healthcare J.P. Morgan Healthcare Conference January 9, 2023 2 Forward-Looking Statements This presentation contains forward-looking statements that express the Company’s opinions, expectations, beliefs, plans, objectives, assumptions or projections regarding future events or future results that include, but are not limited to: 2022 financial guidance and other

Regulation FD Disclosure, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 9, 2023 Privia Health Group, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware 001-40365 81-3599420 (State or other jurisdiction of incorporation or organiz

Entry into a Material Definitive Agreement, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 16, 2022 Privia Health Group, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware 001-40365 81-3599420 (State or other jurisdiction of incorporation or organ

Underwriting Agreement, dated as of November 16, 2022, by and among the Company, the Selling Stockholders and Goldman Sachs & Co. LLC

Exhibit 1.1 Privia Health Group, Inc. Common Stock Underwriting Agreement November 16, 2022 Goldman Sachs & Co. LLC, As representative (the ?Representative?) of the several Underwriters named in Schedule I hereto c/o Goldman Sachs & Co. LLC 200 West Street, New York, New York 10282-2198 Ladies and Gentlemen: The stockholders of Privia Health Group, Inc., a Delaware corporation (the ?Company?) name

II-1

Exhibit 99.1 Information Relating to Part II, Item 14. Other Expenses of Issuance and Distribution The following is a statement of the expenses incurred or expected to be incurred, other than underwriting discounts and commissions, to be paid solely by Privia Health Group, Inc., in connection with the issuance and distribution of the securities being registered hereby. All expenses other than the

5,000,000 Shares Privia Health Group, Inc. Common Stock

Filed Pursuant to Rule 424(b)(7) File No. 333-268394 Prospectus Supplement (To Prospectus dated November 15, 2022) 5,000,000 Shares Privia Health Group, Inc. Common Stock The selling stockholders of Privia Health Group, Inc. (?Privia Health?) named in this prospectus supplement are selling 5,000,000 shares of Privia Health?s common stock. We are not selling any shares under this prospectus supplem

Calculation of Filing Fee Table FORM 424(b)(7) (Form Type) Privia Health Group, Inc. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered Securities

Exhibit 107 Calculation of Filing Fee Table FORM 424(b)(7) (Form Type) Privia Health Group, Inc.

Statement of Eligibility on Form T-1 of U.S. Bank Trust Company, National Association for Subordinated Notes Indenture*

Exhibit 25.2 SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM T-1 STATEMENT OF ELIGIBILITY UNDER THE TRUST INDENTURE ACT OF 1939 OF A CORPORATION DESIGNATED TO ACT AS TRUSTEE Check if an Application to Determine Eligibility of a Trustee Pursuant to Section 305(b)(2) ☐ U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION (Exact name of Trustee as specified in its charter) 91-1821036 I.R.S. E

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 14, 2022 Privia Health G

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 14, 2022 Privia Health Group, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware 001-40365 81-3599420 (State or other jurisdiction of incorporation or organ

Subject to completion dated November 15, 2022

Filed Pursuant to Rule 424(b)(7) File No. 333-268394 The information in this preliminary prospectus supplement is not complete and may be changed. A registration statement relating to these securities has been filed with the Securities and Exchange Commission and is effective. This preliminary prospectus supplement and the accompanying prospectus are not an offer to sell these securities and they

Form of Subordinated Indenture, between Privia Health Group, Inc. and U.S. Bank Trust Company, National Association, as trustee*

Exhibit 4.3 PRIVIA HEALTH GROUP, INC. as the Company and U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION as Trustee Subordinated Indenture Dated as of , 20 TABLE OF CONTENTS Page ARTICLE 1 DEFINITIONS AND INCORPORATION BY REFERENCE Section 1.01. Definitions 1 Section 1.02. Other Definitions 5 Section 1.03. Incorporation by Reference of Trust Indenture Act 5 Section 1.04. Rules of Construction 5 ARTI

As filed with the Securities and Exchange Commission on November 15, 2022

As filed with the Securities and Exchange Commission on November 15, 2022 Registration No.

Statement of Eligibility on Form T-1 of U.S. Bank Trust Company, National Association for Senior Notes Indenture*

Exhibit 25.1 SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM T-1 STATEMENT OF ELIGIBILITY UNDER THE TRUST INDENTURE ACT OF 1939 OF A CORPORATION DESIGNATED TO ACT AS TRUSTEE Check if an Application to Determine Eligibility of a Trustee Pursuant to Section 305(b)(2) ☐ U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION (Exact name of Trustee as specified in its charter) 91-1821036 I.R.S. E

Calculation of Filing Fee

Exhibit 107 Calculation of Filing Fee Tables FORM S-3 Registration Statement Under the Securities Act of 1933 (Form Type) Privia Health Group, Inc.

Privia Health Announces Change to its Board of Directors

EX-99.1 Exhibit 99.1 Privia Health Announces Change to its Board of Directors ARLINGTON, VA – November 15, 2022 – Privia Health Group, Inc. (Nasdaq: PRVA) today announced that Jeff Butler has resigned from the Company’s Board of Directors and as a member of the Compliance Committee of the Board, effective immediately. Mr. Butler’s resignation was not due to any disagreement with the Company on any

Form of Senior Notes Indenture, between Privia Health Group, Inc. and U.S. Bank Trust Company, National Association, as trustee*

Exhibit 4.2 PRIVIA HEALTH GROUP, INC. as the Company and U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION as Trustee Senior Indenture Dated as of , 20 TABLE OF CONTENTS Page ARTICLE 1 DEFINITIONS AND INCORPORATION BY REFERENCE Section 1.01. Definitions 1 Section 1.02. Other Definitions 4 Section 1.03. Incorporation by Reference of Trust Indenture Act 4 Section 1.04. Rules of Construction 4 ARTICLE 2

Privia Health Reports Third Quarter 2022 Financial Results

Exhibit 99.1 Privia Health Reports Third Quarter 2022 Financial Results –Results and outlook reflect strong year-to-date performance and business momentum –Implemented Providers +27.2% compared to 3Q’21 –Practice Collections +52.4% compared to 3Q’21 –Shared savings of ~$100 million achieved through Medicare Shared Savings Program in 2021 –New market entries announced with health systems in North C

Second Amended and Restated Bylaws of Privia Health Group, Inc., adopted and in effect as November 9, 2022

Exhibit 3.1 SECOND AMENDED AND RESTATED BYLAWS OF PRIVIA HEALTH GROUP, INC., a Delaware Corporation (the ?Corporation?) Adopted and in effect as of November 9, 2022 ***** ARTICLE 1 OFFICES Section 1.01. Registered Office. The registered office of the Corporation shall be in the State of Delaware, as designated from time to time by the appropriate filing by the Corporation in the office of the Secr

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 10, 2022 Privia Health Group, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware 001-40365 81-3599420 (State or other jurisdiction of incorporation or organ

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file numbe

Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 9, 2022 Privia Health Group, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware 001-40365 81-3599420 (State or other jurisdiction of incorporation or organi

Employment Agreement second amendment between Privia Health Group, Inc. and Shawn Morris, dated April 1, 2020

EXHIBIT 10.2 AMENDMENT TO TO THE EXECUTIVE EMPLOYMENT AGREEMENT AND NON-QUALIFIED STOCK OPTION PLAN AGREEMENT(S) This Amendment to the Executive Employment Agreement and the Non-Qualified Stock Option Plan Agreement(s) (this ?Amendment?) is effective as of April 1, 2020 (the ?Amendment Effective Date?) by and among Privia Health, LLC (?Privia?), PH Group Parent Corp. (?PH Parent?) and Shawn Morris

Employment Agreement first amendment between Privia Health Group, Inc. and Shawn Morris, dated April 23, 2019

EXHIBIT 10.1 AMENDMENT TO THE EXECUTIVE EMPLOYMENT AGREEMENT This AMENDMENT TO THE EXECUTIVE EMPLOYMENT AGREEMENT (the ?Amendment?), dated as of April 23, 2019 (the ?Amendment Effective Date?), is by and between PH Group Parent Corp., a Delaware corporation (collectively, the ?Company?) and Shawn Morris (the ?Executive?). Company and Executive are each referred to herein individually as a ?Party?

Employment Agreement third amendment between Privia Health Group, Inc. and Shawn Morris, dated August 10, 2022

Exhibit 10.3 THIRD AMENDMENT TO EMPLOYMENT AGREEMENT This THIRD AMENDMENT TO EMPLOYMENT AGREEMENT (this ?Amendment?), dated the 10th day of August, 2022, is entered into by and between Privia Health Group, Inc. f/k/a PH Group Parent Corp. (?PHG?), Privia Health, LLC (?Privia?) and Shawn Morris (?Executive?). Each of PHG, Privia and Executive may be referred to individually herein as a ?Party? or,

Employment Agreement fourth amendment between Privia Health Group, Inc. and Thomas Bartrum, dated August 10, 2022

Exhibit 10.8 FOURTH AMENDMENT TO EXECUTIVE EMPLOYMENT AGREEMENT This FOURTH AMENDMENT TO EXECUTIVE EMPLOYMENT AGREEMENT (this ?Amendment?), dated the 10th day of August, 2022, is entered into by and between Privia Health, LLC (?Company?) and Thomas Bartrum (?Executive?). Each of Company and Executive may be referred to individually herein as a ?Party? or, collectively, as the ?Parties.? RECITALS W

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001

Employment Agreement first amendment between Privia Health Group, Inc. and David Mountcastle, dated August 10, 2022

Exhibit 10.7 FIRST AMENDMENT TO EXECUTIVE EMPLOYMENT AGREEMENT This FIRST AMENDMENT TO EXECUTIVE EMPLOYMENT AGREEMENT (this ?Amendment?), dated the 10th day of August, 2022, is entered into by and between Privia Health, LLC (?Company?) and David Mountcastle (?Executive?). Each of Company and Executive may be referred to individually herein as a ?Party? or, collectively, as the ?Parties.? RECITALS

Employment Agreement third amendment between Privia Health Group, Inc. and Parth Mehrotra, dated August 10, 2022

Exhibit 10.6 THIRD AMENDMENT TO EXECUTIVE EMPLOYMENT AGREEMENT This THIRD AMENDMENT TO EXECUTIVE EMPLOYMENT AGREEMENT (this ?Amendment?), dated the 10th day of August, 2022, is entered into by and between Privia Health, LLC (?Company?) and Parth Mehrotra (?Executive?). Each of Company and Executive may be referred to individually herein as a ?Party? or, collectively, as the ?Parties.? RECITALS WHE

Employment Agreement second amendment between Privia Health Group, Inc. and Parth Mehrotra, dated April 16, 2021

EXHIBIT 10.5 SECOND AMENDMENT TO TO THE EXECUTIVE EMPLOYMENT AGREEMENT This Second Amendment to the Executive Employment Agreement (this ?Amendment?) is effective as of April 16, 2021 (the ?Amendment Effective Date?) by and between Privia Health, LLC (?Privia?) and Parth Mehrotra (?Executive?). Privia and Executive are hereinafter each a ?Party? and collectively the ?Parties?. W I T N E S S E T H:

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 11, 2022 Privia Health Group, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware 001-40365 81-3599420 (State or other jurisdiction of incorporation or organiz

Employment Agreement first amendment between Privia Health Group, Inc. and Parth Mehrotra, dated April 1, 2020

EXHIBIT 10.4 FIRST AMENDMENT TO TO THE EXECUTIVE EMPLOYMENT AGREEMENT AND NON-QUALIFIED STOCK OPTION PLAN AGREEMENT(S) This First Amendment to the Executive Employment Agreement and the Non-Qualified Stock Option Plan Agreement(s) (this ?Amendment?) is effective as of April 1, 2020 (the ?Amendment Effective Date?) by and among Privia Health, LLC (?Privia?), PH Group Parent Corp. (?PH Parent?) and

Privia Health Reports Second Quarter 2022 Financial Results

Exhibit 99.1 Privia Health Reports Second Quarter 2022 Financial Results ?Updated guidance reflects strong first half performance and continued business momentum ?Practice Collections +67.6% compared to 2Q?21 ?Implemented Providers +31.5% compared to 2Q?21 ?Repaid all outstanding debt in the quarter ARLINGTON, VA ? August 11, 2022 ? Privia Health Group, Inc. (Nasdaq: PRVA) today announced financia

Regulation FD Disclosure

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 1, 2022 Privia Health Group, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware 001-40365 81-3599420 (State or other jurisdiction of incorporation or organizati

Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 24, 2022 Privia Health Group, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware 001-40365 81-3599420 (State or other jurisdiction of incorporation or organizat

Regulation FD Disclosure, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 7, 2022 Privia Health Group, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware 001-40365 81-3599420 (State or other jurisdiction of incorporation or organizati

1 Empowering Physicians Transforming Healthcare William Blair Growth Conference June 7, 2022 2 Forward-Looking Statements This presentation contains forward-looking statements that express the Company’s opinions, expectations, beliefs, plans, objecti

1 Empowering Physicians Transforming Healthcare William Blair Growth Conference June 7, 2022 2 Forward-Looking Statements This presentation contains forward-looking statements that express the Company?s opinions, expectations, beliefs, plans, objectives, assumptions or projections regarding future events or future results that include, but are not limited to: 2022 financial guidance and other projections and forecasts.

Submission of Matters to a Vote of Security Holders

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 11, 2022 Privia Health Group, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware 001-40365 81-3599420 (State or other jurisdiction of incorporation or organizati

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 00

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 12, 2022 Privia Health Group, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware 001-40365 81-3599420 (State or other jurisdiction of incorporation or organizati

Privia Health Reports First Quarter 2022 Financial Results

Exhibit 99.1 Privia Health Reports First Quarter 2022 Financial Results ?Updated financial guidance reflects strong Q1 performance and business momentum ?Practice Collections +63.3% compared to 1Q?21 ?Implemented Providers +27.3% compared to 1Q?21 ?Value-Based Care Attributed Lives +17.6% compared to 1Q?21 ARLINGTON, VA ? May 12, 2022 ? Privia Health Group, Inc. (Nasdaq: PRVA) today announced fina

PRVA / Privia Health Group, Inc. / Pamplona Capital Partners III, L.P. Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.)

DEF 14A 1 d269986ddef14a.htm DEF 14A Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Comm

PRVA / Privia Health Group, Inc. / Sullivan William M - SC 13G Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. ) * Privia Health Group, Inc. (Name of Issuer) Common Stock, $.01 par value (Title of Class of Securities) 74276R102 (CUSIP Number) December 31, 2021 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule purs

Regulation FD Disclosure, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 30, 2022 Privia Health Group, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware 001-40365 81-3599420 (State or other jurisdiction of incorporation or organiza

Nancy Cocozza Joins Privia Health’s Board of Directors

Exhibit 99.1 Nancy Cocozza Joins Privia Health?s Board of Directors ARLINGTON, VA ? March 31, 2022 ? Privia Health Group, Inc. (Nasdaq: PRVA) today announced the addition of Nancy Cocozza to its Board of Directors, increasing its Board to ten members. Ms. Cocozza, a former senior vice president and Medicare business leader with Aetna, will also serve on the Board?s Audit Committee. ?Nancy brings a

Description of Capital Stock

Exhibit 4.2 DESCRIPTION OF CAPITAL STOCK General Our authorized capital stock consists of 1,000,000,000 shares of common stock, $0.01 per share, and 100,000,000 shares of preferred stock, par value $0.01 per share. As of March , 2022, we had shares of common stock outstanding. The following description of our capital stock is intended as a summary only and is qualified in its entirety by reference

Employment Agreement third amendment between Privia Health Group, Inc. and Thomas Bartrum, dated March 24, 2022

Exhibit 10.8 THIRD AMENDMENT TO EXECUTIVE EMPLOYMENT AGREEMENT This THIRD AMENDMENT TO EXECUTIVE EMPLOYMENT AGREEMENT (this ?Amendment?), effective as of March 24, 2022, is entered into by and between Privia Health, LLC (?Company?) and Thomas Bartrum (?Executive?). Each of Company and Executive may be referred to individually herein as a ?Party? or, collectively, as the ?Parties.? RECITALS WHEREAS

Notice of Modification of Option Agreement

Privia Health Group, Inc. 950 N. Glebe Road, Suite 700 Arlington, VA 22203 To: Optionholder From: Privia Health Group, Inc. Date: August 24, 2021 Re: Notice of Modification of Option Agreement This notice is being provided to you because you currently hold one or more options to purchase shares in the Privia Health Group, Inc. (the ?Company?). Each Option was granted to you pursuant to a stock opt

Annual Merit Increase and Bonus Payment Memo for Parth Mehrotra dated March 12, 2021

Privia Health 950 N Glebe Road, Suite 700 Arlington VA, 22203 Memorandum TO: Parth Mehrotra FROM: hr@priviahealth.

Subsidiaries of the registrant

Exhibit 21.1 List of Subsidiaries of Privia Health Group, Inc. Legal Name of Entity Jurisdiction of Formation Bass Privia Management Company of California, LLC CA Complete MD Solutions, LLC TX Patient Health Advocacy Solutions, LLC DE PH Group Holdings Corp. (f/k/a Brighton Health Services Holdings Corp.) DE PMG POL, LLC DE PQN-Central Texas, LLC DE PQN-Georgia, LLC GA Privia Care Center, LLC VA P

Employment Agreement first amendment between Privia Health Group, Inc. and Thomas Bartrum, dated April 1, 2020

Exhibit 10.6 FIRST AMENDMENT TO TO THE EXECUTIVE EMPLOYMENT AGREEMENT AND NON-QUALIFIED STOCK OPTION PLAN AGREEMENT(S) This First Amendment to the Executive Employment Agreement and the Non-Qualified Stock Option Plan Agreement(s) (this ?Amendment?) is effective as of April 1, 2020 (the ?Amendment Effective Date?) by and among Privia Health, LLC (?Privia?), PH Group Parent Corp. (?PH Parent?) and

Employment Agreement second amendment between Privia Health Group, Inc. and Thomas Bartrum, dated April 16, 2021

Exhibit 10.7 SECOND AMENDMENT TO TO THE EXECUTIVE EMPLOYMENT AGREEMENT This Second Amendment to the Executive Employment Agreement (this ?Amendment?) is effective as of April 16, 2021 (the ?Amendment Effective Date?) by and between Privia Health, LLC (?Privia?) and Thomas Bartrum (?Executive?). Privia and Executive are hereinafter each a ?Party? and collectively the ?Parties?. W I T N E S S E T H:

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the year ended December 31, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-40365 Priv

Privia Health Reports Fourth Quarter 2021 Financial Results

Exhibit 99.1 Privia Health Reports Fourth Quarter 2021 Financial Results ?FY 2021 Financial Results Above High End of Guidance ?FY 2022 Guidance Highlights Practice Collections Growth of 30.7% at Midpoint ?Entries into California, Montana and West Texas help to Accelerate 2022 Growth ?Launches Three New ACOs; Four Existing ACOs participating in MSSP Enhanced Track ?Enters Two New Capitated Arrange

, 2022, by and between the Company and David Mountcastle.

Exhibit 10.1 Executive Employment Agreement This Executive Employment Agreement (?Agreement?) entered into as of the 21st day of March, 2022 (?Effective Date?), by and between Privia Health, LLC (?Company?) and David Mountcastle (?Executive?), together (the ?Parties?). Recitals WHEREAS, Company is engaged in the business of owning, operating and providing management services to certain accountable

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 22, 2022 Privia Health Group, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware 001-40365 81-3599420 (State or other jurisdiction of incorporation or organiza

Separation and Release of Claims Agreement, dated as of March 21, 2022, between the Company and Jeffrey S. Sherman.

Exhibit 10.2 Separation and Release of Claims Agreement This Separation and Release of Claims Agreement ("Agreement") is entered into by and between Privia Health, LLC, a Delaware limited liability company, (the "Employer") on behalf of itself, its parent organizations, subsidiaries and other corporate affiliates and each of their respective employees, officers, directors, owners, shareholders and

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 16, 2022 Privia Health Group, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware 001-40365 81-3599420 (State or other jurisdiction of incorporation or organiza

PRVA / Privia Health Group, Inc. / Pamplona Capital Partners III, L.P. - SC 13G Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No.

JOINT FILING STATEMENT PURSUANT TO RULE 13d-1(k)

JOINT FILING STATEMENT PURSUANT TO RULE 13d-1(k) The undersigned acknowledge and agree that the foregoing statement on Schedule 13G, is filed on behalf of each of the undersigned and that all subsequent amendments to this statement on Schedule 13G, shall be filed on behalf of each of the undersigned without the necessity of filing additional joint acquisition statements.

Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 31, 2022 Privia Health Group, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware 001-40365 81-3599420 (State or other jurisdiction of incorporation or organi

Regulation FD Disclosure, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 10, 2022 Privia Health Group, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware 001-40365 81-3599420 (State or other jurisdiction of incorporation or organi

PROPRIETARY AND CONFIDENTIAL J.P. Morgan Healthcare Conference January 10, 2022 Empowering Physicians TRANSFORMING HEALTHCARE 2 Forward-Looking Statements This presentation contains forward-looking statements that express the Company’s opinions, expe

PROPRIETARY AND CONFIDENTIAL J.P. Morgan Healthcare Conference January 10, 2022 Empowering Physicians TRANSFORMING HEALTHCARE 2 Forward-Looking Statements This presentation contains forward-looking statements that express the Company?s opinions, expectations, beliefs, plans, objectives, assumptions or projections regarding future events or future results. These forward-looking statements involve a

Transition Letter Agreement, dated as of January 6, 2022, between the Company and David Mountcastle.

Exhibit 10.1 Privia Health 950 N. Glebe Road, Suite 700 Arlington, VA 22203 January 6, 2022 Via Email: [email protected] Re: Transition from Privia Health Dear David: As we have discussed, we expect the Board to appoint Jeff Sherman as Chief Financial Officer of the Company (?CFO?) later this week. Based upon your conversation with Shawn Morris, we understand that you desire to transit

Jeff Sherman Joins Privia Health as Chief Financial Officer

Exhibit 99.1 Jeff Sherman Joins Privia Health as Chief Financial Officer ARLINGTON, VA ? January 6, 2022 ? Privia Health Group, Inc. (Nasdaq: PRVA) announced that Jeffrey S. Sherman will join the company as Executive Vice President and Chief Financial Officer (CFO), effective immediately. Mr. Sherman will report to Privia Health?s Chief Executive Officer, Shawn Morris, and will be responsible for

Employment Agreement, dated as of January 2, 2022, between the Company and Jeffrey S. Sherman.

Exhibit 10.1 Executive Employment Agreement This Executive Employment Agreement (?Agreement?) entered into as of the second day of January 2022 (?Effective Date?), by and between Privia Health, LLC (?Company?) and Jeffrey Sherman (?Executive?), together (the ?Parties?). Recitals WHEREAS, Company is engaged in the business of owning, operating and providing management services to certain accountabl

Regulation FD Disclosure, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 1, 2022 Privia Health Group, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware 001-40365 81-3599420 (State or other jurisdiction of incorporation or organiz

Regulation FD Disclosure, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 21, 2021 Privia Health Group, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware 001-40365 81-3599420 (State or other jurisdiction of incorporation or organ

What is Privia Health? Privia Health is building the leading next generation physician organization and care delivery network Our revolutionary business model is comprised of three interdependent elements: ü Single TIN Medical Group ü Risk-Bearing En

Exhibit 99.1 Empowering Physicians TRANSFORMING HEALTHCARE Piper Sandler Value-Based Care Webinar December 21, 2021 PROPRIETARY AND CONFIDENTIAL Disclaimer Forward-Looking Statements This presentation contains forward-looking statements that express the Company?s opinions, expectations, beliefs, plans, objectives, assumptions or projections regarding future events or future results. These forward-

6,000,000 Shares Privia Health Group, Inc. Common Stock

Filed Pursuant to Rule 424(b)(4) File No. 333-261120 PROSPECTUS 6,000,000 Shares Privia Health Group, Inc. Common Stock The selling shareholders of Privia Health Group, Inc. (?Privia Health?) named in this prospectus are selling 6,000,000 shares of Privia Health?s common stock. We are not selling any shares under this prospectus and will not receive any proceeds from the sale of shares by the sell

[Signature Page Follows]

November 16, 2021 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Re: Privia Health Group, Inc. Registration Statement on Form S-1 Registration No. 333-261120 Acceleration Request Requested Date: November 18, 2021 Requested Time: 4:00 PM, Eastern Time Ladies and Gentlemen: In accordance with Rule 461 under the Securities A

Form of Underwriting Agreement

EX-1.1 2 exhibit11-sx1.htm EX-1.1 Exhibit 1.1 Privia Health Group, Inc. Common Stock Underwriting Agreement [•], 2021 Goldman Sachs & Co. LLC, J.P. Morgan Securities LLC, As representatives (the “Representatives”) of the several Underwriters named in Schedule I hereto c/o Goldman Sachs & Co. LLC 200 West Street, New York, New York 10282-2198 c/o J.P. Morgan Securities LLC 383 Madison Avenue, New Y

Privia Health Group, Inc. 950 N. Glebe Rd., Suite 700 Arlington, VA 22203

Privia Health Group, Inc. 950 N. Glebe Rd., Suite 700 Arlington, VA 22203 VIA EDGAR TRANSMISSION November 16, 2021 Division of Corporation Finance U.S. Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549-3628 RE: Privia Health Group, Inc. Registration Statement on Form S-1, as amended (File No. 333-261120) Request for Acceleration of Effective Date Ladies and Gentlemen: Pu

As filed with the Securities and Exchange Commission on November 16, 2021

As filed with the Securities and Exchange Commission on November 16, 2021 Registration No.

Amendment No. 1 to the Registration Rights Agreement between Privia Health Group, Inc. and the other signatories party thereto dated October 29, 2021

Exhibit 10.11 AMENDMENT NO. 1 TO REGISTRATION RIGHTS AGREEMENT This Amendment No. 1 (this ?Amendment?), effective as of August 29, 2021, is made to that certain Registration Rights Agreement, dated as of May 2, 2021 (this ?Agreement?), by and among Privia Health Group, Inc., a Delaware corporation (the ?Company?), Brighton Health Group Holdings, LLC, and the parties listed on Schedule I thereto. W

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file numbe

Privia Health Reports Third Quarter 2021 Financial Results

Exhibit 99.1 Privia Health Reports Third Quarter 2021 Financial Results ?Raises Full-Year 2021 Guidance on All Metrics ?Record New Provider Growth ?Strong Performance in 2020 MSSP and Other Value-based Programs ?Entry into California and West Texas Markets to Accelerate Growth ARLINGTON, VA ? November 8, 2021 ? Privia Health Group, Inc. (Nasdaq: PRVA) today announced financial results for the thir

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 8, 2021 Privia Health Group, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware 001-40365 81-3599420 (State or other jurisdiction of incorporation or organi

Amendment No. 1 to the Registration Rights Agreement between Privia Health Group, Inc. and the other signatories party thereto dated October 29, 2021

Exhibit 10.11 AMENDMENT NO. 1 TO REGISTRATION RIGHTS AGREEMENT This Amendment No. 1 (this ?Amendment?), effective as of October 29, 2021, is made to that certain Registration Rights Agreement, dated as of May 2, 2021 (this ?Agreement?), by and among Privia Health Group, Inc., a Delaware corporation (the ?Company?), Brighton Health Group Holdings, LLC, and the parties listed on Schedule I thereto.

Assumption Agreement and Third Amendment to the Credit Agreement, dated August 27, 2021, by and among Privia Health Group, Inc., as parent guarantor, Privia Health, LLC, as the borrower, certain other subsidiaries of Privia Health Group, Inc., as guarantors, Silicon Valley Bank, as administrative agent and collateral agent, and the several lenders from time to time party thereto (including conformed copy of the Credit Agreement attached as Exhibit B thereto).

EXECUTION VERSION US\000321\00011\25486686.v6 ASSUMPTION AGREEMENT AND THIRD AMENDMENT TO CREDIT AGREEMENT This Assumption Agreement and Third Amendment to Credit Agreement (this ?Amendment?) dated and effective as of August 27, 2021 by and among PRIVIA HEALTH GROUP, INC., a Delaware corporation (?New Parent Guarantor?), PH GROUP HOLDINGS CORP., a Delaware corporation (?Old Parent Guarantor?), PRI

Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 27, 2021 Privia Health Group, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware 001-40365 81-3599420 (State or other jurisdiction of incorporation or organiz

Regulation FD Disclosure, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 16, 2021 Privia Health Group, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware 001-40365 81-3599420 (State or other jurisdiction of incorporation or organiz

PROPRIETARY AND CONFIDENTIAL Investor Presentation August 2021 Empowering Physicians TRANSFORMING HEALTHCARE 2 Forward-Looking Statements This presentation contains forward-looking statements that express the Company’s opinions, expectations, beliefs

PROPRIETARY AND CONFIDENTIAL Investor Presentation August 2021 Empowering Physicians TRANSFORMING HEALTHCARE 2 Forward-Looking Statements This presentation contains forward-looking statements that express the Company?s opinions, expectations, beliefs, plans, objectives, assumptions or projections regarding future events or future results that include, but are not limited to: 2021 financial guidance and other projections and forecasts.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001

Privia Health Reports Second Quarter 2021 Financial Results

Exhibit 99.1 Privia Health Reports Second Quarter 2021 Financial Results ARLINGTON, VA ? August 9, 2021 ? Privia Health Group, Inc. (Nasdaq: PRVA) today announced financial results for the second quarter and six-month periods ended June 30, 2021. Second Quarter Total revenue for the second quarter of 2021 was $225.8 million, compared to total revenue of $183.3 million for the prior year second qua

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 9, 2021 Privia Health Group, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware 001-40365 81-3599420 (State or other jurisdiction of incorporation or organiza

As confidentially submitted to the Securities and Exchange Commission on July 27, 2021

As confidentially submitted to the Securities and Exchange Commission on July 27, 2021 Registration No.

Dr. Jaewon Ryu Joins Privia Health’s Board of Directors

EX-99.1 2 ex-991pressreleasexdirecto.htm EX-99.1 Exhibit 99.1 Dr. Jaewon Ryu Joins Privia Health’s Board of Directors ARLINGTON, VA – June 30, 2021 – Privia Health Group, Inc. (Nasdaq: PRVA) today announced that Jaewon Ryu, MD, JD, has been elected to the Company’s Board of Directors, effective immediately. In connection with this election, the size of the Board was increased to nine directors. “J

Regulation FD Disclosure, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 28, 2021 Privia Health Group, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware 001-40365 81-3599420 (State or other jurisdiction of incorporation or organizat

Regulation FD Disclosure, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 16, 2021 Privia Health Group, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware 001-40365 81-3599420 (State or other jurisdiction of incorporation or organizat

PROPRIETARY AND CONFIDENTIAL Investor Presentation June 2021 Empowering Physicians TRANSFORMING HEALTHCARE 2 Forward-Looking Statements This presentation contains forward-looking statements that express the Company’s opinions, expectations, beliefs,

EX-99.1 2 exhibit991-priviainvesto.htm EX-99.1 PROPRIETARY AND CONFIDENTIAL Investor Presentation June 2021 Empowering Physicians TRANSFORMING HEALTHCARE 2 Forward-Looking Statements This presentation contains forward-looking statements that express the Company’s opinions, expectations, beliefs, plans, objectives, assumptions or projections regarding future events or future results that include, b

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 00

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 27, 2021 Privia Health Group, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware 001-40365 81-3599420 (State or other jurisdiction of incorporation or organizati

Privia Health Reports First Quarter 2021 Financial Results

Exhibit 99.1 Privia Health Reports First Quarter 2021 Financial Results ARLINGTON, VA ? May 27, 2021 ? Privia Health Group, Inc. (Nasdaq: PRVA), a technology-driven, national physician enablement company that collaborates with medical groups, health plans and health systems, today announced financial results for the first quarter ended March 31, 2021. ?We started 2021 with strong first quarter res

REGISTRATION RIGHTS AGREEMENT

Exhibit 10.1 REGISTRATION RIGHTS AGREEMENT TABLE OF CONTENTS PAGE ARTICLE 1 DEFINITIONS Section 1.01. Defined Terms 1 Section 1.02. General Interpretive Principles 5 ARTICLE 2 REGISTRATION RIGHTS Section 2.01. Registration 6 Section 2.02. Piggyback Registrations 10 Section 2.03. Selection of Underwriter(s), etc. 11 Section 2.04. Registration Procedures 11 Section 2.05. Holdback Agreements 16 Secti

Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Entry into a Material Definitive Agreement, Material Modification to Rights of Security Holders, Unregistered Sales of Equity Securities, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 2, 2021 Privia Health Group, Inc.

You’ve Exceeded the SEC’s Traffic Limit

Exhibit 10.2 PRIVIA HEALTH GROUP, INC. SHAREHOLDER RIGHTS AGREEMENT Dated as of May 2, 2021 TABLE OF CONTENTS Page Article I DEFINITIONS 1 Section 1.1 Definitions 1 Section 1.2 General Interpretive Principles 6 Article II REPRESENTATIONS AND WARRANTIES 6 Section 2.1 Representations and Warranties of the Investors 6 Section 2.2 Representations and Warranties of the Company 7 Article III MANAGEMENT

Amended and Restated By-Laws (incorporated by reference to Exhibit 3.2 to the Company’s Current Report on Form 8-K (Commission File No. 001-40365) filed on May 3, 2021)

Exhibit 3.2 BYLAWS OF PRIVIA HEALTH GROUP, INC. * * * * * ARTICLE 1 OFFICES Section 1.01. Registered Office. The registered office of the Corporation shall be in the City of Wilmington, County of New Castle, State of Delaware. Section 1.02. Other Offices. The Corporation may also have offices at such other places both within and without the State of Delaware as the Board of Directors may from time

Amended and Restated Certificate of Incorporation (incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K (Commission File No. 001-40365) filed on May 3, 2021)

Exhibit 3.1 AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF PRIVIA HEALTH GROUP, INC. Privia Health Group, Inc., a corporation organized and existing under the laws of the State of Delaware (the ?Corporation?), hereby certifies that the Corporation was originally incorporated under the name ?PH Group Parent Corp.? on August 10, 2016, and that its original Certificate of Incorporation was file

19,500,000 Shares Privia Health Group, Inc. Common Stock

Table of Contents Filed Pursuant to Rule 424(b)(4) Registration Number: 333-255086 PROSPECTUS 19,500,000 Shares Privia Health Group, Inc.

Second Amended and Restated PH Group Parent Corp. Stock Option Plan (incorporated by reference to Exhibit 99.2 to the Company’s Registration Statement on Form S-8 (Commission File No. 333-255598) filed on April 29, 2021)

EX-99.2 6 dp150081ex9902.htm EXHIBIT 99.2 Exhibit 99.2 SECOND AMENDED AND RESTATED PH GROUP PARENT CORP. StOCK OPTION PLAN (As Amended Through August 28, 2018) 1. Purpose. The purpose of the Plan is to assist the Company to attract, retain, incentivize and motivate officers and employees of, consultants to, and non-employee directors providing services to, the Company and its Subsidiaries and to p

Privia Health Group, Inc. Employee Stock Purchase Plan (incorporated by reference to Exhibit 99 to the Company’s Registration Statement on Form S-8 (Commission File No. 333-255593) filed on April 29, 2021)

Exhibit 99 PRIVIA HEALTH GROUP, INC. EMPLOYEE STOCK PURCHASE PLAN Section 1. Purpose. This Privia Health Group, Inc. Employee Stock Purchase Plan is intended to provide employees of the Company and its Participating Subsidiaries with an opportunity to acquire a proprietary interest in the Company through the purchase of Shares. The Company intends that the Plan qualify as an ?employee stock purcha

Form of Non-Qualified Stock Option Agreement under the Second Amended and Restated PH Group Parent Corp. Stock Option Plan (incorporated by reference to Exhibit 99.3 to the Company’s Registration Statement on Form S-8 (Commission File No. 333-255598) filed on April 29, 2021)

EX-99.3 7 dp150081ex9903.htm EXHIBIT 99.3 Exhibit 99.3 SECOND AMENDED AND RESTATED PH GROUP PARENT CORP. STOCK OPTION PLAN BASE OPTION POOL NONQUALIFIED STOCK OPTION AGREEMENT THIS NONQUALIFIED STOCK OPTION AGREEMENT (the “Agreement”), effective as of the date of grant set forth on the signature page hereto (the “Date of Grant”), is between PH Group Parent Corp., a Delaware corporation (the “Compa

2021 Omnibus Incentive Plan (incorporated herein by reference to Exhibit

Exhibit 99.1 PRIVIA HEALTH GROUP, INC. 2021 OMNIBUS INCENTIVE PLAN Section 1. Purpose. The purpose of the Privia Health Group, Inc. 2021 Omnibus Incentive Plan (as amended from time to time, the ?Plan?) is to motivate and reward employees and other individuals to perform at the highest level and contribute significantly to the success of Privia Health Group, Inc. (the ?Company?), thereby furtherin

- FORM S-8

As filed with the Securities and Exchange Commission on April 28, 2021 Registration No.

Form of Amendment to Non-Qualified Stock Option Agreement under Second Amended and Restated PH Group Parent Corp. Stock Option Plan (filed herewith)

Exhibit 99.4 To: Optionholder From: Privia Health Group, Inc. Date: Re: Notice of Modifications to Option Agreement This notice is being provided to you because you currently hold one or more options to purchase Shares in the Company (each an ?Option?). Each Option was granted pursuant to a stock option agreement between you and the Company (each an ?Option Agreement?). You should refer to your Op

- FORM S-8

As filed with the Securities and Exchange Commission on April 28, 2021 Registration No.

- S-1/A

Table of Contents As filed with the Securities and Exchange Commission on April 28, 2021 Registration No.

Form 8-A

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-A FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(b) OR 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 Privia Health Group, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware 85-3599420 (State of Incorporation or Organization) (I.R.S. Employer Identification No.) 950 N. Glebe Road Suite 700 Ar

[Signature Page Follows]

April 26, 2021 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Re: Privia Health Group, Inc. Registration Statement on Form S-1 Registration No. 333-255086 Acceleration Request Requested Date: April 28, 2021 Requested Time: 4:00 PM, Eastern Time Ladies and Gentlemen: In accordance with Rule 461 under the Securities Act of

Privia Health Group, Inc. 950 N. Glebe Rd., Suite 700 Arlington, VA 22203

Privia Health Group, Inc. 950 N. Glebe Rd., Suite 700 Arlington, VA 22203 April 26, 2021 VIA EDGAR Division of Corporation Finance U.S. Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549-3628 Attention: Ms. Celeste Murphy Mr. Chris Edwards Re: Privia Health Group, Inc. Registration Statement on Form S-1 Registration No. 333-255086 Dear Ms. Murphy and Mr. Edwards: Pursuant

Form of Shareholder Rights Agreement between Privia Health Group, Inc. and the other signatories party thereto

Exhibit 10.5 PRIVIA HEALTH GROUP, INC. SHAREHOLDER RIGHTS AGREEMENT Dated as of [?], 2021 TABLE OF CONTENTS Page Article I DEFINITIONS 1 Section 1.1 Definitions 1 Section 1.2 General Interpretive Principles 6 Article II REPRESENTATIONS AND WARRANTIES 6 Section 2.1 Representations and Warranties of the Investors 6 Section 2.2 Representations and Warranties of the Company 7 Article III MANAGEMENT 7

Subsidiaries of the registrant

Exhibit 21.1 Subsidiaries of the Registrant Entity Name Jurisdiction of Organization Complete MD Solutions, LLC TX Patient Health Advocacy Solutions, LLC DE PH Group Holdings Corp. (f/k/a Brighton Health Services Holdings Corp.) DE PMG POL, LLC DE PQN-Central Texas, LLC DE PQN-Georgia, LLC GA Privia Care Center, LLC VA Privia Care Partner Georgia, LLC (f/k/a Privia Independent Physicians Associati

Employee Stock Purchase Plan (incorporated herein by reference to Exhibit 10.7 to the registrant’s Registration Statement on Form S-1 (File No. 333-255086), filed with the SEC on April 22, 2021)

Exhibit 10.7 PRIVIA HEALTH GROUP, INC. EMPLOYEE STOCK PURCHASE PLAN Section 1. Purpose. This Privia Health Group, Inc. Employee Stock Purchase Plan is intended to provide employees of the Company and its Participating Subsidiaries with an opportunity to acquire a proprietary interest in the Company through the purchase of Shares. The Company intends that the Plan qualify as an ?employee stock purc

Form of 2021 Omnibus Plan Stock Option Award (incorporated herein by reference to Exhibit 10.10 to the registrant’s Registration Statement on Form S-1 (File No. 333-255086), filed with the SEC on April 22, 2021)

Exhibit 10.10 PRIVIA HEALTH GROUP, INC. 2021 OMNIBUS INCENTIVE PLAN NOTICE OF STOCK OPTION AWARD [DATE] Privia Health Group, Inc., a Delaware corporation (the ?Company?), has granted the individual listed below as the Participant, effective as of the Grant Date (as set forth below), an award (the ?Award?) of the number of Non-Qualified Stock Options (the ?Options?) to purchase shares of the Compan

2

New York Northern California Washington DC S?o Paulo London Paris Madrid Tokyo Beijing Hong Kong Richard D.

Form of 2021 Omnibus Plan Restricted Stock Unit Award for Non-Employee Directors (incorporated herein by reference to Exhibit 10.9 to the registrant’s Registration Statement on Form S-1 (File No. 333-255086), filed with the SEC on April 22, 2021)

Exhibit 10.9 PRIVIA HEALTH GROUP, INC. 2021 OMNIBUS INCENTIVE PLAN NOTICE OF NON-EMPLOYEE DIRECTOR RESTRICTED STOCK UNIT AWARD [DATE] Privia Health Group, Inc., a Delaware corporation (the ?Company?), has granted the non-employee director of the Company listed below as the Participant, effective as of the Grant Date (as set forth below), a Restricted Stock Unit Award (the ?Award?) under the Privia

Form of Registration Rights Agreement between Privia Health Group, Inc. and the other signatories party thereto

Exhibit 10.6 REGISTRATION RIGHTS AGREEMENT TABLE OF CONTENTS Page ARTICLE 1 DEFINITIONS Section 1.01. Defined Terms 1 Section 1.02. General Interpretive Principles 5 ARTICLE 2 REGISTRATION RIGHTS Section 2.01. Registration 5 Section 2.02. Piggyback Registrations 10 Section 2.03. Selection of Underwriter(s), etc. 11 Section 2.04. Registration Procedures 11 Section 2.05. Holdback Agreements 16 Secti

- S-1/A

Table of Contents As filed with the Securities and Exchange Commission on April 22, 2021 Registration No.

- S-1/A

Table of Contents As filed with the Securities and Exchange Commission on April 22, 2021 Registration No.

Form of 2021 Omnibus Plan Restricted Stock Unit Award for Employees (incorporated herein by reference to Exhibit 10.8 to the registrant’s Registration Statement on Form S-1 (File No. 333-255086), filed with the SEC on April 22, 2021)

Exhibit 10.8 PRIVIA HEALTH GROUP, INC. 2021 OMNIBUS INCENTIVE PLAN NOTICE OF RESTRICTED STOCK UNIT AWARD [DATE] Privia Health Group, Inc., a Delaware corporation (the ?Company?), has granted the individual listed below as the Participant, effective as of the Grant Date (as set forth below), a Restricted Stock Unit Award (the ?Award?) under the Privia Health Group, Inc. 2021 Omnibus Incentive Plan

Form of Underwriting Agreement

Exhibit 1.1 Privia Health Group, Inc. Common Stock Underwriting Agreement [?], 2021 Goldman Sachs & Co. LLC, J.P. Morgan Securities LLC, As representatives (the ?Representatives?) of the several Underwriters named in Schedule I hereto, c/o Goldman Sachs & Co. LLC 200 West Street, New York, New York 10282-2198 c/o J.P. Morgan Securities LLC 383 Madison Avenue, New York, New York 10179-0001 Ladies a

Consent of Patricia Maryland

Exhibit 99.3 Consent to be Named as a Director Nominee In connection with the filing by Privia Health Group, Inc. of the Registration Statement on Form S-1 (the ?Registration Statement?) with the Securities and Exchange Commission under the Securities Act of 1933, as amended (the ?Securities Act?), I hereby consent, pursuant to Rule 438 of the Securities Act, to being named as a nominee to the boa

2

New York Northern California Washington DC S?o Paulo London Paris Madrid Tokyo Beijing Hong Kong Davis Polk & Wardwell LLP 450 Lexington Avenue New York, NY 10017 212 450 4000 tel 212 701 5800 fax April 21, 2021 Re: Privia Health Group, Inc.

Type of Option

New York Northern California Washington DC S?o Paulo London Paris Madrid Tokyo Beijing Hong Kong Richard Truesdell Davis Polk & Wardwell LLP 450 Lexington Avenue New York, NY 10017 212 450 4674 tel 212 701 5674 fax richard.

Power of Attorney (included on signature page)

Table of Contents As filed with the Securities and Exchange Commission on April 7, 2021 Registration No.

Employment Agreement between Privia Health Group, Inc. and Thomas Bartrum, dated February 25, 2019

Exhibit 10.4 Executive Employment Agreement This Executive Employment Agreement (?Agreement?) entered into as of (the ?Effective Date?), by and between Privia Health, LLC (?Company?) and Thomas Bartrum (?Executive?), together (the ?Parties?). Recitals WHEREAS, Company is engaged in the business of owning, operating and providing management services to certain accountable care organizations, physic

Form of Common Stock Certificate (incorporated herein by reference to Exhibit 4.1 to the registrant’s Registration Statement on Form S-1 (File No. 333-255086), filed with the SEC on April 7, 2021)

Exhibit 4.1 NUMBER PRIVIA TM HEALTH SHARES INCORPORATED UNDER THE LAWS OF THE STATE OF DELAWARE SEE REVERSE SIDE FOR CERTAIN DEFINITIONS CUSIP TO COME THIS CERTIFIES THAT is the owner of FULLY PAID AND NON-ASSESSABLE COMMON SHARES, $0.01 PAR VALUE, OF PRIVIA HEALTH GROUP, INC. transferable on the books of the Corporation by the holder hereof in person or by Attorney upon surrender of this certific

Employment Agreement between Privia Health Group, Inc. and Shawn Morris, dated April 13, 2018

Exhibit 10.2 EXECUTION VERSION EMPLOYMENT AGREEMENT THIS EMPLOYMENT AGREEMENT (this ?Agreement?) is made as of April 13, 2018 (the ?Effective Date?) between PH Group Parent Corp., a Delaware corporation (the ?Company?), and Shawn Morris (?Executive?). Certain definitions are set forth in Section 9 of this Agreement. WHEREAS, the Company wishes to employ Executive, and Executive wishes to accept su

Consent of David King

Exhibit 99.1 Consent to be Named as a Director Nominee In connection with the filing by Privia Health Group, Inc. of the Registration Statement on Form S-1 (the ?Registration Statement?) with the Securities and Exchange Commission under the Securities Act of 1933, as amended (the ?Securities Act?), I hereby consent, pursuant to Rule 438 of the Securities Act, to being named as a nominee to the boa

Amended and Restated Certificate of Incorporation

Exhibit 3.1 AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF PRIVIA HEALTH GROUP, INC. Privia Health Group, Inc., a corporation organized and existing under the laws of the State of Delaware (the ?Corporation?), hereby certifies that the Corporation was originally incorporated under the name ?PH Group Parent Corporation? on August 10, 2016, and that its original Certificate of Incorporation wa

Amended and Restated By-Laws

Exhibit 3.2 AMENDED AND RESTATED BYLAWS OF PRIVIA HEALTH GROUP, INC., a Delaware Corporation (the ?Corporation?) Adopted and in effect as of [?], 2021 ***** ARTICLE 1 OFFICES Section 1.01. Registered Office. The registered office of the Corporation shall be in the State of Delaware, as designated from time to time by the appropriate filing by the Corporation in the office of the Secretary of State

Employment Agreement between Privia Health Group, Inc. and Parth Mehrotra, dated January 1, 2018

Exhibit 10.3 Executive Employment Agreement This Executive Employment Agreement (?Agreement?) by and among Privia Health, LLC (?Privia?), Brighton Health Management Corp. (?Brighton?), and Parth Mehrotra (the ?Executive?). This Agreement is effective as January 1, 2018 (the ?Effective Date?). Between January 1, 2018 and December 31, 2018, any reference to ?Company? shall mean Brighton. On and afte

Consent of Thomas McCarthy

Exhibit 99.2 Consent to be Named as a Director Nominee In connection with the filing by Privia Health Group, Inc. of the Registration Statement on Form S-1 (the ?Registration Statement?) with the Securities and Exchange Commission under the Securities Act of 1933, as amended (the ?Securities Act?), I hereby consent, pursuant to Rule 438 of the Securities Act, to being named as a nominee to the boa

2021 Omnibus Incentive Plan

Exhibit 10.1 PRIVIA HEALTH GROUP, INC. 2021 OMNIBUS INCENTIVE PLAN Section 1. Purpose. The purpose of the Privia Health Group, Inc. 2021 Omnibus Incentive Plan (as amended from time to time, the ?Plan?) is to motivate and reward employees and other individuals to perform at the highest level and contribute significantly to the success of Privia Health Group, Inc. (the ?Company?), thereby furtherin

Subsidiaries of the registrant

Exhibit 21.1 Subsidiaries of the Registrant Entity Name Jurisdiction of Organization Complete MD Solutions, LLC TX Patient Health Advocacy Solutions, LLC DE PH Group Holdings Corp. (f/k/a Brighton Health Services Holdings Corp.) DE PMG POL, LLC DE PQN-Central Texas, LLC DE PQN-Georgia, LLC GA Privia Care Center, LLC VA Privia DC Metro Management Company, LLC DE Privia Health, LLC DE Privia Indepen

As confidentially submitted to the Securities and Exchange Commission on March 16, 2021

Table of Contents As confidentially submitted to the Securities and Exchange Commission on March 16, 2021 Registration No.

2

New York Northern California Washington DC S?o Paulo London Paris Madrid Tokyo Beijing Hong Kong Richard D.

As confidentially submitted to the Securities and Exchange Commission on February 12, 2021

DRS/A 1 filename1.htm Table of Contents As confidentially submitted to the Securities and Exchange Commission on February 12, 2021 Registration No. 333- SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 CONFIDENTIAL DRAFT SUBMISSION NO. 2 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Privia Health Group, Inc. (Exact Name of Registrant as Specified in Its Charter) Delawar

2

New York Northern California Washington DC S?o Paulo London Paris Madrid Tokyo Beijing Hong Kong Richard D.

New York

New York Northern California Washington DC S?o Paulo London Paris Madrid Tokyo Beijing Hong Kong Richard D.

As confidentially submitted to the Securities and Exchange Commission on December 28, 2020

Table of Contents As confidentially submitted to the Securities and Exchange Commission on December 28, 2020 Registration No.